Viewing Study NCT05686551

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-01 @ 3:20 AM
Study NCT ID: NCT05686551
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-18
First Post: 2022-12-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Huntington Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prodromal and Early Manifest Huntington's Disease View